Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Pharoah

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Personalized Medicine|September 18, 2012
Population-based screening in the era of genomicsNora Pashayan, Paul Pharoah
Epidemiology (Cambridge, Mass.)|May 26, 2010
Risk factors for breast cancer: a reanalysis of two case-control studies from 1926 and 1931David J Press, Paul Pharoah
Cancer Cell|September 18, 2020
Cancer Screening, Surrogates of Survival, and the SomaJames DeGregori, Paul Pharoah, Peter Sasieni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysisAdam S Butterworth, Julian P T Higgins, Paul Pharoah
Hereditary Cancer in Clinical Practice|June 3, 2016
Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling studyCharlotte Warren-Gash, Mark Kroese, Hilary Burton, et al.
BMC Medicine|June 17, 2020
Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)David Thurtle, Ola Bratt, Pär Stattin, et al.
BMC Geriatrics|May 8, 2020
Usual physical activity and subsequent hospital usage over 20 years in a general population: the EPIC-Norfolk cohortRobert Luben, Shabina Hayat, Nicholas Wareham, et al.
BMJ Open|June 24, 2019
Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic reviewDavid Thurtle, Sabrina H Rossi, Brendan Berry, et al.
Plos Medicine|March 3, 2006
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studiesZheng Ye, Honglin Song, Julian P T Higgins, et al.
Nature Genetics|March 29, 2013
Public health implications from COGS and potential for risk stratification and screeningHilary Burton, Susmita Chowdhury, Tom Dent, et al.
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Personalized Medicine|September 18, 2012
Population-based screening in the era of genomicsNora Pashayan, Paul Pharoah
Epidemiology (Cambridge, Mass.)|May 26, 2010
Risk factors for breast cancer: a reanalysis of two case-control studies from 1926 and 1931David J Press, Paul Pharoah
Cancer Cell|September 18, 2020
Cancer Screening, Surrogates of Survival, and the SomaJames DeGregori, Paul Pharoah, Peter Sasieni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysisAdam S Butterworth, Julian P T Higgins, Paul Pharoah
Hereditary Cancer in Clinical Practice|June 3, 2016
Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling studyCharlotte Warren-Gash, Mark Kroese, Hilary Burton, et al.
BMC Medicine|June 17, 2020
Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)David Thurtle, Ola Bratt, Pär Stattin, et al.
BMC Geriatrics|May 8, 2020
Usual physical activity and subsequent hospital usage over 20 years in a general population: the EPIC-Norfolk cohortRobert Luben, Shabina Hayat, Nicholas Wareham, et al.
BMJ Open|June 24, 2019
Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic reviewDavid Thurtle, Sabrina H Rossi, Brendan Berry, et al.
Plos Medicine|March 3, 2006
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studiesZheng Ye, Honglin Song, Julian P T Higgins, et al.
Nature Genetics|March 29, 2013
Public health implications from COGS and potential for risk stratification and screeningHilary Burton, Susmita Chowdhury, Tom Dent, et al.
Pageof 16